{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T17:39:17Z","timestamp":1773509957886,"version":"3.50.1"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","award":["MISP 61171"],"award-info":[{"award-number":["MISP 61171"]}],"id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s10461-025-04936-z","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T15:07:16Z","timestamp":1761577636000},"page":"834-848","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preferences and Trade-offs for Attributes of Long-Acting HIV Prevention Products Among Pregnant and Breastfeeding Women in Kenya: A Discrete Choice Experiment"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-4976-5096","authenticated-orcid":false,"given":"Sophia M.","family":"Ngugi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Echoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Were","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Thuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vallery","family":"Ogello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelson","family":"Muteti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Mwangi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Kazungu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Ngure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"key":"4936_CR1","unstructured":"WHO. HIV and AIDS [Internet]. 2023 [cited 2024 Jul 6].\u00a0https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hiv-aids"},{"key":"4936_CR2","unstructured":"Global HIV. & AIDS statistics \u2014 Fact sheet [Internet]. [cited 2024 Nov 29].\u00a0https:\/\/www.unaids.org\/en\/resources\/fact-sheet"},{"key":"4936_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001608","volume":"11","author":"AL Drake","year":"2014","unstructured":"Drake AL, Wagner A, Richardson B, John-Stewart G. Incident HIV during pregnancy and postpartum and risk of mother-to-child HIV transmission: a systematic review and meta-analysis. PLoS Med. 2014;11:e1001608.","journal-title":"PLoS Med"},{"key":"4936_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/infdis\/jiy118","volume":"218","author":"LM Mofenson","year":"2018","unstructured":"Mofenson LM. Risk of HIV acquisition during pregnancy and postpartum: a call for action. J Infect Dis. 2018;218:1\u20134.","journal-title":"J Infect Dis"},{"key":"4936_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1177\/1933719108325510","volume":"16","author":"JS Sheffield","year":"2009","unstructured":"Sheffield JS, Wendel GD, McIntire DD, Norgard MV. The effect of progesterone levels and pregnancy on HIV-1 coreceptor expression. Reprod Sci. 2009;16:20\u201331.","journal-title":"Reprod Sci"},{"key":"4936_CR6","doi-asserted-by":"crossref","unstructured":"Abadan SS, Hawryluk L, Montandon M, Flowers N, Schueller J, Eakle R et al. Preexposure prophylaxis among pregnant and lactating people in 18 PEPFAR-supported countries: a review of HIV strategies and guidelines. Global Health: Science and Practice [Internet]. 2022 [cited 2024 Jul 30];10. https:\/\/www.ghspjournal.org\/content\/10\/6\/e2200129","DOI":"10.9745\/GHSP-D-22-00129"},{"key":"4936_CR7","unstructured":"World Health Organization. Preventing HIV during pregnancy and breastfeeding in the context of PREP. 2017 Jul."},{"key":"4936_CR8","unstructured":"Full report \u2014. In Danger: UNAIDS Global AIDS Update 2022 | UNAIDS [Internet]. [cited 2025 Apr 19]. https:\/\/www.unaids.org\/en\/resources\/documents\/2022\/in-danger-global-aids-update"},{"key":"4936_CR9","unstructured":"WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach [Internet]. 2nd ed. Geneva: World Health Organization. 2016 [cited 2024 Feb 11].\u00a0https:\/\/iris.who.int\/handle\/10665\/208825"},{"key":"4936_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/frph.2023.1221752","author":"LJ Masenyetse","year":"2023","unstructured":"Masenyetse LJ, Greenberg L, Samonyane F, Sekepe B, Mokone M, Mokone MJ, et al. Oral HIV pre-exposure prophylaxis use among pregnant and postpartum women: results from real-world implementation in Lesotho. Front Reprod Health. 2023. https:\/\/doi.org\/10.3389\/frph.2023.1221752.","journal-title":"Front Reprod Health"},{"key":"4936_CR11","doi-asserted-by":"publisher","first-page":"e154","DOI":"10.1016\/S2352-3018(22)00369-1","volume":"10","author":"D Moodley","year":"2023","unstructured":"Moodley D, Lombard C, Govender V, Naidoo M, Desmond AC, Naidoo K, et al. Pregnancy and neonatal safety outcomes of timing of initiation of daily oral Tenofovir disoproxil fumarate and emtricitabine pre-exposure prophylaxis for HIV prevention (CAP016): an open-label, randomised, non-inferiority trial. Lancet HIV. 2023;10:e154\u201363.","journal-title":"Lancet HIV"},{"key":"4936_CR12","unstructured":"United Nations Children\u2019s Fund. Improving the quality of pre-exposure prophylaxis implementation for adolescent girls and young women in Eastern and Southern Africa: Implementation brief. 2021 Sep."},{"key":"4936_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.26044","volume":"25","author":"D Joseph Davey","year":"2022","unstructured":"Joseph Davey D, Nyemba DC, Castillo-Mancilla J, Wiesner L, Norman J, Mvududu R, et al. Adherence challenges with daily oral pre\u2010exposure prophylaxis during pregnancy and the postpartum period in South African women: a cohort study. J Int AIDS Soc. 2022;25:e26044.","journal-title":"J Int AIDS Soc"},{"key":"4936_CR14","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1097\/QAD.0000000000003617","volume":"37","author":"J Pintye","year":"2023","unstructured":"Pintye J, Kinuthia J, Abuna F, Anderson PL, Dettinger JC, Gomez L, et al. HIV pre-exposure prophylaxis initiation, persistence, and adherence during pregnancy through the postpartum period. AIDS. 2023;37:1725.","journal-title":"AIDS"},{"key":"4936_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003670","volume":"18","author":"C Celum","year":"2021","unstructured":"Celum C, Hosek S, Tsholwana M, Kassim S, Mukaka S, Dye BJ, et al. PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in Southern africa: results from HPTN 082, a randomized controlled trial. PLoS Med. 2021;18:e1003670.","journal-title":"PLoS Med"},{"key":"4936_CR16","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1080\/17425247.2022.2135699","volume":"19","author":"V Agrahari","year":"2022","unstructured":"Agrahari V, Anderson SM, Peet MM, Wong AP, Singh ON, Doncel GF, et al. Long-acting HIV pre-exposure prophylaxis (PrEP) approaches: recent advances, emerging technologies, and development challenges. Expert Opin Drug Deliv. 2022;19:1365\u201380.","journal-title":"Expert Opin Drug Deliv"},{"key":"4936_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002690","volume":"15","author":"RJ Landovitz","year":"2018","unstructured":"Landovitz RJ, Li S, Grinsztejn B, Dawood H, Liu AY, Magnus M, et al. Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial. PLoS Med. 2018;15:e1002690.","journal-title":"PLoS Med"},{"key":"4936_CR18","doi-asserted-by":"publisher","first-page":"3913","DOI":"10.1128\/AAC.00656-15","volume":"59","author":"M Gunawardana","year":"2015","unstructured":"Gunawardana M, Remedios-Chan M, Miller CS, Fanter R, Yang F, Marzinke MA, et al. Pharmacokinetics of long-acting Tenofovir Alafenamide (GS-7340) subdermal implant for HIV prophylaxis. Antimicrob Agents Chemother. 2015;59:3913\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"4936_CR19","unstructured":"IAVI. Evolving access pathways for long-acting HIV prevention products [Internet]. IAVI. 2021 [cited 2024 Mar 16].\u00a0http:\/\/www.iavi.org\/features\/evolving-access-pathways-for-long-acting-hiv-prevention-products\/"},{"key":"4936_CR20","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1056\/NEJMoa2407001","volume":"391","author":"L-G Bekker","year":"2024","unstructured":"Bekker L-G, Das M, Karim QA, Ahmed K, Batting J, Brumskine W, et al. Twice-yearly lenacapavir or daily F\/TAF for HIV prevention in cisgender women. N Engl J Med. 2024;391:1179\u201392.","journal-title":"N Engl J Med"},{"key":"4936_CR21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2411858","author":"CF Kelley","year":"2025","unstructured":"Kelley CF, Acevedo-Qui\u00f1ones M, Agwu AL, Avihingsanon A, Benson P, Blumenthal J, et al. Twice-yearly Lenacapavir for HIV prevention in men and gender-diverse persons. New England J Med. 2025. https:\/\/doi.org\/10.1056\/NEJMoa2411858.","journal-title":"New England J Med"},{"key":"4936_CR22","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1056\/NEJMoa1506110","volume":"375","author":"JM Baeten","year":"2016","unstructured":"Baeten JM, Palanee-Phillips T, Brown ER, Schwartz K, Soto-Torres LE, Govender V, et al. Use of a vaginal ring containing Dapivirine for HIV-1 prevention in women. N Engl J Med. 2016;375:2121\u201332.","journal-title":"N Engl J Med"},{"key":"4936_CR23","unstructured":"WHO. WHO recommends the dapivirine. vaginal ring as a new choice for HIV prevention for women at substantial risk of HIV infection [Internet]. 2021 [cited 2024 Jul 30].\u00a0https:\/\/www.who.int\/news\/item\/26-01-2021-who-recommends-the-dapivirine-vaginal-ring-as-a-new-choice-for-hiv-prevention-for-women-at-substantial-risk-of-hiv-infection"},{"key":"4936_CR24","unstructured":"Kristen Jill Kresge. IAVI, REPORT \u2013 NO. 1, 2021 [Internet]. IAVI. 2021 [cited 2024 Jul 30]. http:\/\/www.iavi.org\/iavi-report\/iavi-report-vol-25-no-1-2021\/"},{"key":"4936_CR25","doi-asserted-by":"publisher","first-page":"e00152","DOI":"10.1128\/cmr.00152-22","volume":"37","author":"S Mahomed","year":"2024","unstructured":"Mahomed S. Broadly neutralizing antibodies for HIV prevention: a comprehensive review and future perspectives. Clin Microbiol Rev. 2024;37:e00152\u201322.","journal-title":"Clin Microbiol Rev"},{"key":"4936_CR26","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1016\/j.antiviral.2013.09.019","volume":"100","author":"M Brady","year":"2013","unstructured":"Brady M, Manning J. Lessons from reproductive health to inform multipurpose prevention technologies: don\u2019t reinvent the wheel. Antiviral Res. 2013;100:S25\u201331.","journal-title":"Antiviral Res"},{"key":"4936_CR27","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s40273-018-0734-2","volume":"37","author":"V Soekhai","year":"2019","unstructured":"Soekhai V, de Bekker-Grob EW, Ellis AR, Vass CM. Discrete choice experiments in health economics: past, present and future. Pharmacoeconomics. 2019;37:201\u201326.","journal-title":"Pharmacoeconomics"},{"key":"4936_CR28","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s40258-023-00794-9","volume":"21","author":"H Wang","year":"2023","unstructured":"Wang H, Rowen DL, Brazier JE, Jiang L. Discrete choice experiments in health state valuation: a systematic review of progress and new trends. Appl Health Econ Health Policy. 2023;21:405\u201318.","journal-title":"Appl Health Econ Health Policy"},{"key":"4936_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e18256","volume":"9","author":"AS Alamri","year":"2023","unstructured":"Alamri AS, Georgiou S, Stylianou S. Discrete choice experiments: an overview on constructing D-optimal and near-optimal choice sets. Heliyon. 2023;9:e18256.","journal-title":"Heliyon"},{"key":"4936_CR30","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.8794","volume":"5","author":"NN O\u2019Hara","year":"2022","unstructured":"O\u2019Hara NN. Eliciting health care preferences with discrete choice experiments. JAMA Netw Open. 2022;5:e228794.","journal-title":"JAMA Netw Open"},{"key":"4936_CR31","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1080\/13696998.2020.1735398","volume":"23","author":"AJM Goossens","year":"2020","unstructured":"Goossens AJM, Cheung KL, Sijstermans E, Conde R, Gonzalez JGR, Hiligsmann M. A discrete choice experiment to assess patients\u2019 preferences for HIV treatment in the rural population in Colombia. J Med Econ. 2020;23:803\u201311.","journal-title":"J Med Econ"},{"key":"4936_CR32","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.2147\/PPA.S405288","volume":"17","author":"S Fifer","year":"2023","unstructured":"Fifer S, Kularatne T, Tan M, Drummond F, Rule J. Understanding treatment preferences among people living with HIV in Australia: a discrete choice experiment. PPA. 2023;17:1825\u201343.","journal-title":"PPA"},{"key":"4936_CR33","doi-asserted-by":"publisher","first-page":"100653","DOI":"10.1016\/j.eclinm.2020.100653","volume":"29-30","author":"M Sharma","year":"2020","unstructured":"Sharma M, Ong JJ, Celum C, Terris-Prestholt F. Heterogeneity in individual preferences for HIV testing: A systematic literature review of discrete choice experiments. EClinicalMedicine. 2020;29\u201330:100653.","journal-title":"EClinicalMedicine"},{"key":"4936_CR34","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1080\/13696998.2022.2055937","volume":"25","author":"P Chiwire","year":"2022","unstructured":"Chiwire P, M\u00fchlbacher AC, Evers SM, Mahomed H, Ostermann J, Hiligsmann M. A discrete choice experiment investigating HIV testing preferences in South Africa. J Med Econ. 2022;25:481\u201390.","journal-title":"J Med Econ"},{"key":"4936_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0255650","volume":"16","author":"S Dommaraju","year":"2021","unstructured":"Dommaraju S, Hagey J, Odeny TA, Okaka S, Kadima J, Bukusi EA, et al. Preferences of people living with HIV for differentiated care models in kenya: a discrete choice experiment. PLoS ONE. 2021;16:e0255650.","journal-title":"PLoS ONE"},{"key":"4936_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-05399-4","volume":"20","author":"P Vickerman","year":"2020","unstructured":"Vickerman P, Quaife M, Kilbourne-Brook M, Mvundura M, Eakle R, Terris-Prestholt F. HIV prevention is not all about HIV \u2013 using a discrete choice experiment among women to model how the uptake and effectiveness of HIV prevention products may also rely on pregnancy and STI protection. BMC Infect Dis. 2020;20:704.","journal-title":"BMC Infect Dis"},{"key":"4936_CR37","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1177\/0272989X17729376","volume":"38","author":"M Quaife","year":"2018","unstructured":"Quaife M, Eakle R, Cabrera Escobar MA, Vickerman P, Kilbourne-Brook M, Mvundura M, et al. Divergent preferences for HIV prevention: a discrete choice experiment for multipurpose HIV prevention products in South Africa. Med Decis Making. 2018;38:120\u201333.","journal-title":"Med Decis Making"},{"key":"4936_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25528","volume":"23","author":"AM Minnis","year":"2020","unstructured":"Minnis AM, Atujuna M, Browne EN, Ndwayana S, Hartmann M, Sindelo S, et al. Preferences for long\u2010acting pre\u2010exposure prophylaxis (PrEP) for HIV prevention among South African youth: results of a discrete choice experiment. J Int AIDS Soc. 2020;23:e25528.","journal-title":"J Int AIDS Soc"},{"key":"4936_CR39","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-069195","volume":"13","author":"Y Chen","year":"2023","unstructured":"Chen Y, Saldarriaga EM, Montano MA, Ngure K, Thuo N, Kiptinness C, et al. Assessing preferences for HIV pre-exposure prophylaxis (PrEP) delivery services via online pharmacies in Kenya: protocol for a discrete choice experiment. BMJ Open. 2023;13:e069195.","journal-title":"BMJ Open"},{"key":"4936_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/frph.2023.1156864","author":"NL Bhushan","year":"2023","unstructured":"Bhushan NL, Ridgeway K, Luecke EH, Palanee-Phillips T, Montgomery ET, Minnis AM. Synthesis of end-user research to inform future multipurpose prevention technologies in sub-Saharan Africa: a scoping review. Front Reprod Health. 2023. https:\/\/doi.org\/10.3389\/frph.2023.1156864.","journal-title":"Front Reprod Health"},{"key":"4936_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-024-10414-z","volume":"25","author":"V Ogello","year":"2025","unstructured":"Ogello V, Mwangi P, Kwena Z, Thuo N, Makokha C, Owidi E, et al. Preferences for and acceptability of long-acting HIV prevention products among pregnant and lactating women accessing health services in Kenya: a mixed method cross-sectional analysis. BMC Infect Dis. 2025;25:37.","journal-title":"BMC Infect Dis"},{"key":"4936_CR42","unstructured":"National Syndemic Disease Control Council. Translating Progress into Success: A Decade of Progress Report 2013\u20132024. 2024."},{"key":"4936_CR43","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jval.2016.04.004","volume":"19","author":"AB Hauber","year":"2016","unstructured":"Hauber AB, Gonz\u00e1lez JM, Groothuis-Oudshoorn CGM, Prior T, Marshall DA, Cunningham C, et al. Statistical methods for the analysis of discrete choice experiments: a report of the ISPOR conjoint analysis good research practices task force. Value Health. 2016;19:300\u201315.","journal-title":"Value Health"},{"issue":"4","key":"4936_CR44","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.jval.2010.11.013","volume":"14","author":"JFP Bridges","year":"2011","unstructured":"Bridges JFP, Hauber AB, Marshall D, Lloyd A, Prosser LA, Regier DA, et al. Conjoint analysis applications in health\u2014a checklist: a report of the ISPOR good research practices for conjoint analysis task force. Value Health. 2011;14(4):403\u201313.","journal-title":"Value Health"},{"key":"4936_CR45","unstructured":"WHO. How to conduct a discrete choice experiment for health workforce recruitment and retention in remote and rural areas: a user guide with case studies. [Internet]. 2012.\u00a0https:\/\/www.capacityplus.org\/files\/resources\/discrete-choice-experiment-user-guide.pdf"},{"key":"4936_CR46","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/heapol\/czn047","volume":"24","author":"LJ Mangham","year":"2009","unstructured":"Mangham LJ, Hanson K, McPake B. How to do (or not to do) \u2026 designing a discrete choice experiment for application in a low-income country. Health Policy Plann. 2009;24:151\u20138.","journal-title":"Health Policy Plann"},{"key":"4936_CR47","doi-asserted-by":"publisher","first-page":"662","DOI":"10.3109\/14659891.2015.1118563","volume":"21","author":"TM Helter","year":"2016","unstructured":"Helter TM, Boehler CEH. Developing attributes for discrete choice experiments in health: a systematic literature review and case study of alcohol misuse interventions. J Subst Use. 2016;21:662\u20138.","journal-title":"J Subst Use"},{"key":"4936_CR48","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-025-04821-9","author":"S Ngugi","year":"2025","unstructured":"Ngugi S, Echoka E, Were V, Kazungu J, Ngure K. Preferences for long-acting HIV pre-exposure prophylaxis among women of reproductive age in low- and middle-income countries: A systematic review. AIDS Behav. 2025. https:\/\/doi.org\/10.1007\/s10461-025-04821-9.","journal-title":"AIDS Behav"},{"key":"4936_CR49","unstructured":"Ngugi S, Echoka E, Were V, Kazungu J, Ngure K. Attribute development and level selection for a discrete choice experiment to examine preferences for long-acting HIV prevention products among pregnant and lactating women in Kenya. Manuscript submitted for publication."},{"key":"4936_CR50","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1524-4733.2009.00670.x","volume":"13","author":"EW de Bekker-Grob","year":"2010","unstructured":"de Bekker-Grob EW, Hol L, Donkers B, van Dam L, Habbema JDF, van Leerdam ME, et al. Labeled versus unlabeled discrete choice experiments in health economics: an application to colorectal cancer screening. Value Health. 2010;13:315\u201323.","journal-title":"Value Health"},{"key":"4936_CR51","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1016\/S0140-6736(22)00538-4","volume":"399","author":"S Delany-Moretlwe","year":"2022","unstructured":"Delany-Moretlwe S, Hughes JP, Bock P, Ouma SG, Hunidzarira P, Kalonji D, et al. Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial. Lancet. 2022;399:1779\u201389.","journal-title":"Lancet"},{"key":"4936_CR52","unstructured":"ChoiceMetrics [Internet]. [cited 2024 Sep 5]. https:\/\/www.choice-metrics.com\/"},{"key":"4936_CR53","unstructured":"McFadden. Conditional logit analysis of qualitative choice behaviour."},{"key":"4936_CR54","unstructured":"Minnis AM, Straten AVD, Cheng HY, Weinrib R, Minnis AM, Agot K et al. End-users\u2019 product preference across three multipurpose prevention technology delivery forms: Baseline results from young women in Kenya and South Africa. 2018 [cited 2024 Dec 2];\u00a0https:\/\/www.rti.org\/publication\/end-users-product-preference-across-three-multipurpose-prevention-technology-delivery-forms-baseline"},{"key":"4936_CR55","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-023-04202-0","author":"KM Little","year":"2023","unstructured":"Little KM, Hanif H, Anderson SM, Clark MR, Gustafson K, Doncel GF. Preferences for long-acting PrEP products among women and girls: a quantitative survey and discrete choice experiment in Eswatini, Kenya, and South Africa. AIDS Behav. 2023. https:\/\/doi.org\/10.1007\/s10461-023-04202-0.","journal-title":"AIDS Behav"},{"key":"4936_CR56","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25426","volume":"23","author":"DL Joseph Davey","year":"2020","unstructured":"Joseph Davey DL, Pintye J, Baeten JM, Aldrovandi G, Baggaley R, Bekker L, et al. Emerging evidence from a systematic review of safety of pre-exposure prophylaxis for pregnant and postpartum women: where are we now and where are we heading? J Int AIDS Soc. 2020;23:e25426.","journal-title":"J Int AIDS Soc"},{"key":"4936_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-023-02181-x","volume":"23","author":"EN Browne","year":"2023","unstructured":"Browne EN, Manenzhe K, Makoni W, Nkomo S, Mahaka I, Ahmed K, et al. Incorporating end-users\u2019 voices into the development of an implant for HIV prevention: a discrete choice experiment in South Africa and Zimbabwe. BMC Womens Health. 2023;23:58.","journal-title":"BMC Womens Health"},{"key":"4936_CR58","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000000511","volume":"32","author":"N Ahmed","year":"2019","unstructured":"Ahmed N, Pike C, Bekker L-G. Scaling up pre-exposure prophylaxis in sub-Saharan Africa. Curr Opin Infect Dis. 2019;32:24.","journal-title":"Curr Opin Infect Dis"},{"key":"4936_CR59","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1080\/09540121.2024.2383878","volume":"36","author":"P Shamu","year":"2024","unstructured":"Shamu P, Mullick S, Christofides NJ. Perceptions of the attributes of new long-acting HIV pre-exposure prophylaxis formulations compared with a daily, oral dose among South African young women: a qualitative study. AIDS Care. 2024;36:1815.","journal-title":"AIDS Care"},{"key":"4936_CR60","doi-asserted-by":"publisher","first-page":"e26088","DOI":"10.1002\/jia2.26088","volume":"26","author":"J Wara Nafisa","year":"2023","unstructured":"Wara Nafisa J, Mvududu R, Marwa MM, G\u00f3mez L, Mashele N, Orrell C, et al. Preferences and acceptability for long-acting PrEP agents among pregnant and postpartum women with experience using daily oral PrEP in South Africa and Kenya. J Int AIDS Soc. 2023;26:e26088.","journal-title":"J Int AIDS Soc"},{"key":"4936_CR61","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1097\/QAD.0000000000001452","volume":"31","author":"ET Montgomery","year":"2017","unstructured":"Montgomery ET, van der Straten A, Chitukuta M, Reddy K, Woeber K, Atujuna M, et al. Acceptability and use of a Dapivirine vaginal ring in a phase III trial. AIDS. 2017;31:1159\u201367.","journal-title":"AIDS"},{"key":"4936_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-023-16955-3","volume":"23","author":"L Fynn","year":"2023","unstructured":"Fynn L, Gill K, Wallace M, Atujuna M, Duyver M, Ngcobo P, et al. It\u2019s already in your body and it\u2019s preventing: a qualitative study of African female adolescent\u2019s acceptability and preferences for proxy HIV prevention methods in cape Town, South Africa. BMC Public Health. 2023;23:2143.","journal-title":"BMC Public Health"},{"key":"4936_CR63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0000981","volume":"2","author":"A Mantsios","year":"2022","unstructured":"Mantsios A, Muraleetharan O, Donastorg Y, Perez M, Gomez H, Shembilu C, et al. She is the one who knows: a qualitative exploration of oral and injectable PrEP as part of a community empowerment approach to HIV prevention among female sex workers in the Dominican Republic and Tanzania. PLoS Glob Public Health. 2022;2:e0000981.","journal-title":"PLoS Glob Public Health"},{"key":"4936_CR64","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25064","volume":"21","author":"M Quaife","year":"2018","unstructured":"Quaife M, Terris-Prestholt F, Eakle R, Cabrera Escobar MA, Kilbourne\u2010Brook M, Mvundura M, et al. The cost\u2010effectiveness of multi\u2010purpose HIV and pregnancy prevention technologies in South Africa. J Intern AIDS Soc. 2018;21:e25064.","journal-title":"J Intern AIDS Soc"},{"key":"4936_CR65","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1007\/s10461-022-03658-w","volume":"26","author":"KM Little","year":"2022","unstructured":"Little KM, Flomen L, Hanif H, Anderson SM, Thurman AR, Clark MR, et al. HIV pre-exposure prophylaxis implant stated preferences and priorities: results of a discrete choice experiment among women and adolescent girls in Gauteng Province, South Africa. AIDS Behav. 2022;26:3099\u2013109.","journal-title":"AIDS Behav"},{"key":"4936_CR66","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/QAI.0000000000001945","volume":"80","author":"AM Minnis","year":"2019","unstructured":"Minnis AM, Browne EN, Boeri M, Agot K, van der Straten A, Ahmed K, et al. Young women\u2019s stated preferences for biomedical HIV prevention: results of a discrete choice experiment in Kenya and South Africa. J Acquir Immune Defic Syndr. 2019;80:394\u2013403.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"4936_CR67","doi-asserted-by":"publisher","DOI":"10.3389\/frph.2023.1169110","author":"A Bershteyn","year":"2023","unstructured":"Bershteyn A, Resar D, Kim H-Y, Platais I, Mullick S. Optimizing the pipeline of multipurpose prevention technologies: opportunities across women\u2019s reproductive lifespans. Front Reprod Health. 2023. https:\/\/doi.org\/10.3389\/frph.2023.1169110.","journal-title":"Front Reprod Health"},{"key":"4936_CR68","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.26301","volume":"27","author":"ML Mugambi","year":"2024","unstructured":"Mugambi ML, Odhiambo BO, Dollah A, Marwa MM, Nyakina J, Kinuthia J, et al. Women\u2019s preferences for HIV prevention service delivery in pharmacies during pregnancy in Western kenya: a discrete choice experiment. J Int AIDS Soc. 2024;27:e26301.","journal-title":"J Int AIDS Soc"},{"key":"4936_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101507","author":"LPL Wulandari","year":"2022","unstructured":"Wulandari LPL, He SY, Fairley CK, Bavinton BR, Schmidt H-M, Wiseman V, et al. Preferences for pre-exposure prophylaxis for HIV: a systematic review of discrete choice experiments. eClinicalMedicine. 2022. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101507.","journal-title":"eClinicalMedicine"},{"key":"4936_CR70","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.whi.2018.08.004","volume":"29","author":"ELP Bradley","year":"2019","unstructured":"Bradley ELP, Hoover KW. Improving HIV preexposure prophylaxis implementation for women: summary of key findings from a discussion series with women\u2019s HIV prevention experts. Womens Health Issues. 2019;29:3\u20137.","journal-title":"Womens Health Issues"},{"key":"4936_CR71","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2019-001809","volume":"4","author":"P Salari","year":"2019","unstructured":"Salari P, Di Giorgio L, Ilinca S, Chuma J. The catastrophic and impoverishing effects of out-of-pocket healthcare payments in Kenya, 2018. BMJ Glob Health. 2019;4:e001809.","journal-title":"BMJ Glob Health"},{"key":"4936_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-025-22291-5","volume":"25","author":"P Stegman","year":"2025","unstructured":"Stegman P, Forsythe S, Kioko U, Kiruki M, Jeckonia P, Larson M, et al. Estimating the cost of and willingness to pay for providing the Dapivirine ring for HIV prevention in Kenya. BMC Public Health. 2025;25:1095.","journal-title":"BMC Public Health"},{"key":"4936_CR73","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s10198-018-0954-6","volume":"19","author":"M Quaife","year":"2018","unstructured":"Quaife M, Terris-Prestholt F, Di Tanna GL, Vickerman P. How well do discrete choice experiments predict health choices? A systematic review and meta-analysis of external validity. Eur J Health Econ. 2018;19:1053\u201366.","journal-title":"Eur J Health Econ"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-025-04936-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-025-04936-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-025-04936-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T13:01:48Z","timestamp":1773493308000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-025-04936-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,27]]},"references-count":73,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["4936"],"URL":"https:\/\/doi.org\/10.1007\/s10461-025-04936-z","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,27]]},"assertion":[{"value":"7 October 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"This study was conducted in accordance with the ethical tenets outlined in the Declaration of. Helsinki. Approval was granted by the Kenya Medical Research Institute (KEMRI) Scientific and Ethics Review Unit (KEMRI\/SERU\/CPHR\/49\/4647). Additionally, permission to conduct the study was granted by the National Commission for Science, Technology, and Innovation, Kenya.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all study participants before data collection, and participants were identified only by unique codes.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}